View in EDS HTML Full Text PDF Full Text

Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study.

Saved in:
Bibliographic Details
Title: Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study.
Authors: Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Min JS; Evidation Health, San Mateo, CA, USA., Lee WN; Evidation Health, San Mateo, CA, USA., Yu JC; Alexion, AstraZeneca Rare Disease, Boston, MA, USA., Patel Y; Alexion, AstraZeneca Rare Disease, Boston, MA, USA., Myren KJ; Health Economics and Outcome Research, Alexion Pharmaceuticals, Inc., Stockholm, Sweden., Dingli D; Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Dingli.David@mayo.edu.
Source: Health and quality of life outcomes [Health Qual Life Outcomes] 2024 Aug 09; Vol. 22 (1), pp. 62. Date of Electronic Publication: 2024 Aug 09.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101153626 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7525 (Electronic) Linking ISSN: 14777525 NLM ISO Abbreviation: Health Qual Life Outcomes Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39123253
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Griffiths+EA%22">Griffiths EA</searchLink>; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Min+JS%22">Min JS</searchLink>; Evidation Health, San Mateo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+WN%22">Lee WN</searchLink>; Evidation Health, San Mateo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yu+JC%22">Yu JC</searchLink>; Alexion, AstraZeneca Rare Disease, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Patel+Y%22">Patel Y</searchLink>; Alexion, AstraZeneca Rare Disease, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Myren+KJ%22">Myren KJ</searchLink>; Health Economics and Outcome Research, Alexion Pharmaceuticals, Inc., Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Dingli+D%22">Dingli D</searchLink>; Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Dingli.David@mayo.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101153626%22">Health and quality of life outcomes</searchLink> [Health Qual Life Outcomes] 2024 Aug 09; Vol. 22 (1), pp. 62. <i>Date of Electronic Publication: </i>2024 Aug 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101153626 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-7525 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214777525%22">14777525 </searchLink><i>NLM ISO Abbreviation: </i>Health Qual Life Outcomes <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39123253
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12955-024-02279-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 62
    Titles:
      – TitleFull: Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Griffiths EA
      – PersonEntity:
          Name:
            NameFull: Min JS
      – PersonEntity:
          Name:
            NameFull: Lee WN
      – PersonEntity:
          Name:
            NameFull: Yu JC
      – PersonEntity:
          Name:
            NameFull: Patel Y
      – PersonEntity:
          Name:
            NameFull: Myren KJ
      – PersonEntity:
          Name:
            NameFull: Dingli D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 08
              Text: 2024 Aug 09
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1477-7525
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Health and quality of life outcomes
              Type: main
ResultId 1